14 research outputs found

    High-throughput molecular assays for inclusion in personalised oncology trials – State-of-the-art and beyond

    Get PDF
    In the last decades, the development of high-throughput molecular assays has revolutionised cancer diagnostics, paving the way for the concept of personalised cancer medicine. This progress has been driven by the introduction of such technologies through biomarker-driven oncology trials. In this review, strengths and limitations of various state-of-the-art sequencing technologies, including gene panel sequencing (DNA and RNA), whole-exome/whole-genome sequencing and whole-transcriptome sequencing, are explored, focusing on their ability to identify clinically relevant biomarkers with diagnostic, prognostic and/or predictive impact. This includes the need to assess complex biomarkers, for example microsatellite instability, tumour mutation burden and homologous recombination deficiency, to identify patients suitable for specific therapies, including immunotherapy. Furthermore, the crucial role of biomarker analysis and multidisciplinary molecular tumour boards in selecting patients for trial inclusion is discussed in relation to various trial concepts, including drug repurposing. Recognising that today's exploratory techniques will evolve into tomorrow's routine diagnostics and clinical study inclusion assays, the importance of emerging technologies for multimodal diagnostics, such as proteomics and in vivo drug sensitivity testing, is also discussed. In addition, key regulatory aspects and the importance of patient engagement in all phases of a clinical trial are described. Finally, we propose a set of recommendations for consideration when planning a new precision cancer medicine trial.imag

    High-throughput molecular assays for inclusion in personalised oncology trials – State-of-the-art and beyond

    Get PDF
    In the last decades, the development of high-throughput molecular assays has revolutionised cancer diagnostics, paving the way for the concept of personalised cancer medicine. This progress has been driven by the introduction of such technologies through biomarker-driven oncology trials. In this review, strengths and limitations of various state-of-the-art sequencing technologies, including gene panel sequencing (DNA and RNA), whole-exome/whole-genome sequencing and whole-transcriptome sequencing, are explored, focusing on their ability to identify clinically relevant biomarkers with diagnostic, prognostic and/or predictive impact. This includes the need to assess complex biomarkers, for example microsatellite instability, tumour mutation burden and homologous recombination deficiency, to identify patients suitable for specific therapies, including immunotherapy. Furthermore, the crucial role of biomarker analysis and multidisciplinary molecular tumour boards in selecting patients for trial inclusion is discussed in relation to various trial concepts, including drug repurposing. Recognising that today's exploratory techniques will evolve into tomorrow's routine diagnostics and clinical study inclusion assays, the importance of emerging technologies for multimodal diagnostics, such as proteomics and in vivo drug sensitivity testing, is also discussed. In addition, key regulatory aspects and the importance of patient engagement in all phases of a clinical trial are described. Finally, we propose a set of recommendations for consideration when planning a new precision cancer medicine trial.imag

    Redefinition of the Requirements Engineer Role in Mjølner’s Software Development Process

    No full text

    Real-time Outlier Detection using Unbounded Data Streaming and Machine Learning

    No full text
    Accelerated advancements in technology, the Internet of Things, and cloud computing have spurred an emergence of unstructured data that is contributing to rapid growth in data volumes. No human can manage to keep up with monitoring and analyzing these unbounded data streams and thus predictive and analytic tools are needed. By leveraging machine learning this data can be converted into insights which are enabling datadriven decisions that can drastically accelerate innovation, improve user experience, and drive operational efficiency. The purpose of this thesis is to design and implement a system for real-time outlier detection using unbounded data streams and machine learning. Traditionally, this is accomplished by using alarm-thresholds on important system metrics. Yet, a static threshold cannot account for changes in trends and seasonality, changes in the system, or an increased system load. Thus, the intention is to leverage machine learning to instead look for deviations in the behavior of the data not caused by natural changes but by malfunctions. The use-case driving the thesis forward is real-time outlier detection in a Content Delivery Network (CDN). The input data includes Http-error messages received by clients, and contextual information like region, cache domains, and error codes, to provide tailormade predictions accounting for the trends in the data. The outlier detection system consists of a data collection pipeline leveraging the technique of stream processing, a MiniBatchKMeans clustering model that provides online clustering of incoming data according to their similar characteristics, and an LSTM AutoEncoder that accounts for temporal nature of the data and detects outlier data points in the clusters. An important finding is that an outlier is defined as an abnormal amount of outlier data points all originating from the same cluster, not a single outlier data point. Thus, the alerting system will be implementing an outlier percentage threshold. The experimental results show that an outlier is detected within one minute from a cache break-down. This triggers an alert to the system owners, containing graphs of the clustered data to narrow down the search area of the cause to enable preventive action towards the prominent incident. Further results show that within 2 minutes from fixing the cause the system will provide feedback that the actions taken were successful. Considering the real-time requirements of the CDN environment, it is concluded that the short delay for detection is indeed real-time. Proving that machine learning is indeed able to detect outliers in unbounded data streams in a real-time manner. Further analysis shows that the system is more accurate during peakhours when more data is in circulation than during none peak-hours, despite the temporal LSTM layers. Presumably, an effect from the model needing to train on more data to better account for seasonality and trends. Future work necessary to put the outlier detection system in production thus includes more training to improve accuracy and correctness. Furthermore, one could consider implementing necessary functionality for a production environment and possibly adding enhancing features that can automatically avert incidents detected and handle the causes of them
    corecore